Acadian Asset Management’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,236
| Closed | -$7K | – | 1697 |
|
|
2023
Q3 | $7K | Sell |
2,236
-3,201
| -59% | -$10K | ﹤0.01% | 1605 |
|
|
2023
Q2 | $22K | Sell |
5,437
-6,161
| -53% | -$24.9K | ﹤0.01% | 1639 |
|
|
2023
Q1 | $99K | Hold |
11,598
| – | – | ﹤0.01% | 1397 |
|
|
2022
Q4 | $151K | Hold |
11,598
| – | – | ﹤0.01% | 1350 |
|
|
2022
Q3 | $198K | Hold |
11,598
| – | – | ﹤0.01% | 1215 |
|
|
2022
Q2 | $127K | Hold |
11,598
| – | – | ﹤0.01% | 1304 |
|
|
2022
Q1 | $256K | Sell |
11,598
-892
| -7% | -$19.7K | ﹤0.01% | 1154 |
|
|
2021
Q4 | $428K | Buy |
+12,490
| New | +$428K | ﹤0.01% | 1050 |
|
|
2021
Q1 | – | Sell |
-2,573
| Closed | -$157K | – | 2108 |
|
|
2020
Q4 | $157K | Buy |
2,573
+606
| +31% | +$37K | ﹤0.01% | 1630 |
|
|
2020
Q3 | $239K | Sell |
1,967
-5,688
| -74% | -$691K | ﹤0.01% | 1385 |
|
|
2020
Q2 | $905K | Buy |
7,655
+2,266
| +42% | +$268K | ﹤0.01% | 995 |
|
|
2020
Q1 | $285K | Buy |
5,389
+346
| +7% | +$18.3K | ﹤0.01% | 1110 |
|
|
2019
Q4 | $274K | Buy |
+5,043
| New | +$274K | ﹤0.01% | 1217 |
|